Alkermes (ALKS) Free Cash Flow (2010 - 2026)
Alkermes (ALKS) posted quarterly Free Cash Flow of $137.0 million for Q2 2026, little changed year-over-year from $137.2 million in Q2 2025, and up 180.69% quarter-over-quarter from -$169.8 million in Q1 2026.
Alkermes (ALKS) Free Cash Flow (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Free Cash Flow for 17 consecutive years, with $137.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Free Cash Flow changed 0.11% year-over-year to $137.0 million; the TTM figure through Jun 2026 stood at $221.7 million (down 53.81% YoY), while the FY2025 annual figure was $480.3 million, up 18.41% from the prior year.
- Free Cash Flow climbed to $137.0 million in Q2 2026 per ALKS's latest filing, from -$169.8 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $206.0 million in Q2 2023 and bottomed at -$169.8 million in Q1 2026.
- Historically, Free Cash Flow has averaged $66.1 million across 5 years, with a median of $84.8 million in 2023.
- On a YoY basis, Free Cash Flow climbed as much as 1779.21% in 2023 and fell as far as 302.79% in 2023.
- Alkermes' Free Cash Flow stood at -$9.0 million in 2022, then soared by 1104.42% to $90.2 million in 2023, then jumped by 100.23% to $180.6 million in 2024, then decreased by 5.83% to $170.1 million in 2025, then slipped by 19.43% to $137.0 million in 2026.
- Business Quant data shows ALKS's Free Cash Flow at $137.0 million in Q2 2026, -$169.8 million in Q1 2026, and $170.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Alkermes | 8.02 Bn | 7.37 Bn | 397.90 Mn | 137.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 137.04 Mn |
| Jun 30, 2026 | 137.04 Mn |
| Mar 31, 2026 | -169.83 Mn |
| Mar 31, 2026 | -169.83 Mn |
| Dec 31, 2025 | 170.09 Mn |
| Dec 31, 2025 | 170.09 Mn |
| Sep 30, 2025 | 84.36 Mn |
| Sep 30, 2025 | 84.36 Mn |
| Jun 30, 2025 | 137.19 Mn |
| Jun 30, 2025 | 137.19 Mn |
| Mar 31, 2025 | 88.70 Mn |
| Mar 31, 2025 | 88.70 Mn |
| Dec 31, 2024 | 180.62 Mn |
| Dec 31, 2024 | 180.62 Mn |
| Sep 30, 2024 | 73.33 Mn |
| Sep 30, 2024 | 73.33 Mn |
| Jun 30, 2024 | 138.92 Mn |
| Jun 30, 2024 | 138.92 Mn |
| Mar 31, 2024 | 12.77 Mn |
| Mar 31, 2024 | 12.77 Mn |